Radiotherapy Combined With PD-1 Inhibitor and GM-CSF for Advanced Recurrent Metastatic Head and Neck Tumors

Clinical trial NCT05760196 · UNKNOWN

Trial details

NCT number: NCT05760196
Sponsor: Xiangpan Li
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Objective Response Rate

Start date: 2022-10-01
Primary completion: 2024-12-31
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.